Crescent Biopharma, Inc. (CBIO) Free cash flow 2016–2025
Crescent Biopharma, Inc. (CBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$72.5MFY2025 · since FY2016: -$30.4M → -$72.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$72.5M | -132.9% |
| FY2024 | -$31.1M | +10.9% |
| FY2023 | -$34.9M | +25.0% |
| FY2022 | -$46.5M | +19.1% |
| FY2021 | -$57.5M | -46.3% |
| FY2020 | -$39.3M | +24.6% |
| FY2019 | -$52.1M | -20.0% |
| FY2018 | -$43.5M | -44.6% |
| FY2017 | -$30.1M | +1.2% |
| FY2016 | -$30.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice